Paydirt
NAMS
Ticker

NewAmsterdam Pharma Company N.V.

NAMS · Healthcare · NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with ca…

NewAmsterdam Pharma Company N.V. (NAMS), in the Healthcare sector, has 19 disclosed filings on Paydirt over the trailing twelve months from 5 corporate insiders: 1 purchase and 18 sales, 1 filed past the deadline. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 30 and filed Oct 2. The most active filer was Louise Frederika Kooij with 6 filings. Data as of Nov 8 2026.

Add to watchlist
Filings, ttm
19
1 buy · 18 sells · 1 late
Traders, ttm
5
5 insiders
Volume, ttmiDollar value disclosed in the window
$63.6M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 30
Filed Oct 2
ADViAverage daily dollar volume
$32.2M
market data
Share price · 12M
$21.26 (-45.4%)
$41.45$31.31$21.16Nov 10 2025Apr 27Oct 8

Adjusted for splits and dividends.

Volume by month
$27.9M$14.0M$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · sells $27.9MJan 2025 · sells $6.4MFeb 2025 · sells $2.0MMar 2025 · sells $6.0MApr 2025 · sells $1.6MMay 2025 · sells $1.9MJun 2025 · buys $167KJun 2025 · sells $1.9MJul 2025 · sells $2.0MAug 2025 · sells $2.7MSep 2025 · sells $4.3MDec 2025 · sells $5.2MJan 2026 · sells $8.8MFeb 2026 · sells $12.1MMar 2026 · sells $26.0MMay 2026 · sells $2.3MJun 2026 · sells $1.2MJul 2026 · sells $3.1MAug 2026 · sells $3.4MSep 2026 · buys $226KOct 2026 · sells $1.3M
Buys $394K Sells $120.1M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
LK Louise Frederika Kooij Chief Accounting Officer 10 filings · 0 buys, 10 sales DK Douglas F Kling Chief Operating Officer 9 filings · 0 buys, 9 sales JK Johannes Jacob Pieter Kastelein Chief Scientific Officer 6 filings · 0 buys, 6 sales MD Michael H. Davidson Chief Executive Officer 5 filings · 1 buy, 4 sales NF NAP B.V. ForGrowth 10% owner 3 filings · 0 buys, 3 sales FV Forbion IV Management B.V. 10% owner 3 filings · 0 buys, 3 sales MS Mayur Ian Somaiya Chief Financial Officer 3 filings · 0 buys, 3 sales FA Forbion Capital Fund IV Cooperatief U.A. 10% owner 2 filings · 0 buys, 2 sales
All 11 filers LL Louis G Lange Director 2 filings · 0 buys, 2 sales FV Forbion Growth Management B.V. 10% owner 1 filing · 0 buys, 1 sale JT James N Topper Director 1 filing · 1 buy, 0 sales
Recent filings
Johannes Jacob Pieter KasteleinSALE Chief Scientific Officer $1.3M
50,246 sh × $25.03
Exec Sep 30
Filed Oct 2 · 4:30 PM ET
Michael H. DavidsonPURCHASE Chief Executive Officer $226K
10,000 sh × $22.65
Exec Sep 14
Filed Sep 15 · 4:30 PM ET
Johannes Jacob Pieter KasteleinSALE Chief Scientific Officer $3.4M
125,000 sh × $26.91
Exec Aug 24
Filed Aug 25 · 4:30 PM ET
Louise Frederika KooijSALE Chief Accounting Officer $3.1M
102,085 sh across 2 lots
Exec Jul 20
Filed Jul 22 · 4:05 PM ET
Louise Frederika KooijSALE Chief Accounting Officer $1.2M
39,700 sh × $30.20
Exec Jun 22
Filed Jun 24 · 5:30 PM ET
Louise Frederika KooijSALE Chief Accounting Officer $2.3M
65,000 sh × $35.69
Exec May 26
Filed May 27 · 5:30 PM ET
Louis G LangeSALE Director $1.3M
44,173 sh × $30.41
Exec Mar 11
Filed Mar 12 · 5:30 PM ET
Louis G LangeSALE Director $829K
28,186 sh × $29.41
Exec Mar 6
Filed Mar 10 · 5:30 PM ET
Johannes Jacob Pieter KasteleinSALE Chief Scientific Officer $9.1M
300,000 sh across 3 lots
Exec Mar 5
Filed Mar 9 · 5:30 PM ET
Michael H. DavidsonSALE Chief Executive Officer $14.8M
443,707 sh × $33.25
Exec Mar 2
Filed Mar 2 · 5:30 PM ET
Michael H. DavidsonSALE Chief Executive Officer $10.5M
304,993 sh across 6 lots
Exec Feb 24
Filed Feb 26 · 5:30 PM ET
Johannes Jacob Pieter KasteleinSALE Chief Scientific Officer $1.6M
45,481 sh across 2 lots
Exec Feb 20
Filed Feb 24 · 5:30 PM ET
Louise Frederika KooijSALE Chief Accounting Officer $2.3M
72,428 sh across 2 lots
Exec Jan 27
Filed Jan 29 · 5:30 PM ET
Louise Frederika KooijSALE Chief Accounting Officer $2.4M
72,263 sh across 3 lots
Exec Jan 23
Filed Jan 27 · 5:30 PM ET
Mayur Ian SomaiyaSALE Chief Financial Officer $3.2M
99,100 sh across 4 lots
Exec Jan 20
Filed Jan 22 · 5:30 PM ET
Michael H. DavidsonSALE Chief Executive Officer $411K
as filed
Exec Jan 7
Filed Jan 9 · 5:30 PM ET
Mayur Ian SomaiyaSALE Chief Financial Officer $170K
5,118 sh × $33.25
Exec Jan 5
Filed Jan 7 · 5:30 PM ET
Johannes Jacob Pieter KasteleinSALE Chief Scientific Officer $200K
6,000 sh × $33.25
Exec Jan 5
Filed Jan 7 · 5:30 PM ET
Louise Frederika KooijSALE Chief Accounting Officer $5.2M
145,000 sh across 3 lots
Exec Dec 23 2025
Filed Dec 29 2025 · 5:30 PM ET †
Louise Frederika KooijSALE Chief Accounting Officer $3.9M
150,000 sh across 2 lots
Exec Sep 9 2025
Filed Sep 10 2025 · 5:30 PM ET
Louise Frederika KooijSALE Chief Accounting Officer $453K
18,073 sh × $25.09
Exec Sep 3 2025
Filed Sep 5 2025 · 5:30 PM ET
Louise Frederika KooijSALE Chief Accounting Officer $206K
8,269 sh × $24.86
Exec Aug 25 2025
Filed Aug 27 2025 · 5:30 PM ET
Johannes Jacob Pieter KasteleinSALE Chief Scientific Officer $2.5M
100,000 sh across 3 lots
Exec Aug 21 2025
Filed Aug 25 2025 · 5:30 PM ET
Douglas F KlingSALE Chief Operating Officer $2.0M
95,068 sh across 2 lots
Exec Jul 15 2025
Filed Jul 17 2025 · 5:30 PM ET
Douglas F KlingSALE Chief Operating Officer $1.9M
100,000 sh across 2 lots
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET